News

Johns Hopkins University researchers discovered that mice can learn new skills in fewer trials than previously assumed. Their study reveals the role of the sensory cortex in learning and challenges the idea that mistakes indicate confusion.

Researchers have studied how dopamine and acetylcholine regulate the progression of sexual behavior in male mice. Their findings may provide insights for developing treatments for sexual dysfunctions like premature ejaculation in humans.

Researchers at UZH have developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse. This should not only speed up the development of new drugs but also reduce the number of laboratory animals required.

A protein called angiopoietin-2 (ANGPT2) can both inhibit and encourage blood vessel changes critical for sepsis, a leading cause of hospital deaths worldwide.

Researchers have found that lecanemab was probably less effective in females than males in the Phase 3 trial of the drug. However, there was insufficient evidence to say the drug was totally ineffective in females.

A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice.

Insights into the fundamental process of how the heart is formed offer new hope for treating heart disease. The findings focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.

Machine learning can predict which adolescents with HIV will be less likely to adhere to therapy. With such knowledge, healthcare practitioners could implement interventions for those identified as less likely to adhere to the treatment plan.

Scientists at St. Jude Children’s Research Hospital have found that frequently used antivirals do not work well against the H5N1 avian influenza virus in cows’ milk.

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.